AQR Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-815
| Closed | -$10.1K | – | 2909 |
|
|
2024
Q3 | $10.1K | Sell |
815
-49,053
| -98% | -$610K | ﹤0.01% | 2748 |
|
|
2024
Q2 | $649K | Buy |
49,868
+41,480
| +495% | +$540K | ﹤0.01% | 1934 |
|
|
2024
Q1 | $190K | Sell |
8,388
-31,488
| -79% | -$713K | ﹤0.01% | 2259 |
|
|
2023
Q4 | $517K | Buy |
39,876
+6,423
| +19% | +$83.3K | ﹤0.01% | 1868 |
|
|
2023
Q3 | $672K | Buy |
33,453
+22,517
| +206% | +$453K | ﹤0.01% | 1747 |
|
|
2023
Q2 | $294K | Buy |
10,936
+5,568
| +104% | +$149K | ﹤0.01% | 1949 |
|
|
2023
Q1 | $313K | Buy |
5,368
+1,258
| +31% | +$73.4K | ﹤0.01% | 1932 |
|
|
2022
Q4 | $210K | Sell |
4,110
-3,402
| -45% | -$173K | ﹤0.01% | 2070 |
|
|
2022
Q3 | $615K | Buy |
7,512
+6,004
| +398% | +$492K | ﹤0.01% | 1700 |
|
|
2022
Q2 | $102K | Sell |
1,508
-347
| -19% | -$23.5K | ﹤0.01% | 2086 |
|
|
2022
Q1 | $205K | Buy |
+1,855
| New | +$205K | ﹤0.01% | 2056 |
|
|
2020
Q4 | – | Sell |
-5,851
| Closed | -$1.28M | – | 2227 |
|
|
2020
Q3 | $1.28M | Sell |
5,851
-224
| -4% | -$49K | ﹤0.01% | 1290 |
|
|
2020
Q2 | $1.73M | Buy |
6,075
+2,094
| +53% | +$595K | ﹤0.01% | 1219 |
|
|
2020
Q1 | $1.15M | Buy |
3,981
+3,208
| +415% | +$924K | ﹤0.01% | 1280 |
|
|
2019
Q4 | $222K | Buy |
+773
| New | +$222K | ﹤0.01% | 1984 |
|
|
2019
Q1 | – | Sell |
-1,706
| Closed | -$240K | – | 2190 |
|
|
2018
Q4 | $240K | Sell |
1,706
-345
| -17% | -$48.5K | ﹤0.01% | 2034 |
|
|
2018
Q3 | $524K | Buy |
2,051
+774
| +61% | +$198K | ﹤0.01% | 1944 |
|
|
2018
Q2 | $325K | Buy |
+1,277
| New | +$325K | ﹤0.01% | 2105 |
|
|
2015
Q2 | – | Sell |
-947
| Closed | -$435K | – | 2236 |
|
|
2015
Q1 | $435K | Buy |
947
+140
| +17% | +$64.3K | ﹤0.01% | 1743 |
|
|
2014
Q4 | $453K | Buy |
+807
| New | +$453K | ﹤0.01% | 2013 |
|